Earnings Call · Q1 FY2025·2025-05-12

Q1 25EPS -7.69%·Rev n/aQ4 24EPS -21.01%·Rev n/aQ3 24EPS +100.00%*·Rev n/aQ2 24EPS -6.25%·Rev n/a⚠ consensus missing

SANGAMO THERAPEUTICS, INC SGMO

Louise Wilkie — Vice President, Investor Relations and Corporate Communications

Sandy Macrae — Chief Executive Officer

Prathyusha Duraibabu — Chief Financial Officer

−4.8%1d on move date−4.9% vs SPY3d+2.2%5d+8.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SGMO calls or request research access.

More SGMO calls Browse calls Request research access